Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05046600 · ClinicalTrials.gov registry record

Registry of Arthrex Hand and Wrist Products

A clinical trial of Arthrodesis and Ulnar/Radial Collateral Ligament Reconstruction, sponsored by Arthrex.

Recruiting
Registry status
650
Enrollment target
5
Study locations

NCT05046600 is a study of Arthrodesis and Ulnar/Radial Collateral Ligament Reconstruction that is actively recruiting participants, run by Arthrex. The registered enrollment target is 650 participants. The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05046600, a study of Arthrodesis and Ulnar/Radial Collateral Ligament Reconstruction, is actively recruiting participants, sponsored by Arthrex.

RECRUITING
Registry status
650 participants
Enrollment target
5
Study locations

Study Summary

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products

Interventions

  • DEVICE Products listed in cohort description

Study Locations (5)

Arizona

  • MORE Foundation - Phoenix
  • Banner Health - Tuscon

Iowa

  • University of Iowa - Iowa City

North Carolina

  • Duke University - Durham

West Virginia

  • West Virginia University - Morgantown

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2021-07-20
Est. Completion 2025-12-01

Sponsor

Arthrex

12 total trials

What the Registry Record Tells You About NCT05046600

The ClinicalTrials.gov registry entry for NCT05046600 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arthrex, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Arthrodesis appearing as the primary indexed condition, and to 1 intervention - of which Products listed in cohort description is the first listed.

NCT05046600 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Iowa, North Carolina.

Frequently Asked Questions

What is clinical trial NCT05046600 about?

NCT05046600 is a clinical study titled "Registry of Arthrex Hand and Wrist Products". A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products

What is the current status of trial NCT05046600?

This trial is currently recruiting. The enrollment target is 650 participants. The study started on 2021-07-20. Estimated completion is 2025-12-01.

What conditions does trial NCT05046600 study?

This clinical trial studies the following conditions: Arthrodesis, Ulnar/Radial Collateral Ligament Reconstruction, Ligament Repair or Reconstruction, Small Bone Fragments and Arthrodesis, Scapholunate Ligament Reconstruction.

What interventions are being tested in trial NCT05046600?

The interventions under investigation include: Products listed in cohort description (DEVICE).

Who is sponsoring clinical trial NCT05046600?

This trial is sponsored by Arthrex, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05046600 being conducted?

This trial has 5 study locations across Arizona, Iowa, North Carolina, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthrodesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.